AstraZeneca PLC (NASDAQ:AZN)
| 65.98 Delayed Data As of Jan 26 |  -0.64 / -0.96%Today’s Change | 52.65 Today|||52-Week Range 72.12 | -2.68% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 5.7B | 7.2B | 6.1B | 5.8B | |
| Cost of Goods Sold | 433.7M | 447.3M | 419.4M | 320.4M | ||
| Depreciation And Amortization | 699.1M | 1.6B | 683.2M | 723.4M | ||
| Operating Expenses | Gross Income | 4.6B | 5.1B | 5.0B | 4.8B | |
| General Expenses | 3.7B | 3.8B | 3.8B | 4.2B | ||
| Research And Development | 1.2B | 2.0B | 1.2B | 1.3B | ||
| Total Operating Expenses | 4.9B | 5.9B | 4.9B | 5.3B | ||
| Non-Operating Expenses | Operating Income | 882.3M | 1.3B | 1.1B | 500.5M | |
| Extraordinary Credit | 0.00 | 714.0M | 0.00 | 0.00 | ||
| Extraordinary Charge | -84.1M | -422.5M | -104.1M | -122.4M | ||
| Interest Expense On Debt | 364.6M | 334.2M | 370.9M | 359.2M | ||
| Equity In Earnings | -44.1M | -35.7M | -27.3M | -31.8M | ||
| Other Expenses | 54.1M | -544.4M | 78.8M | 112.4M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 521.8M | 759.6M | 793.3M | 172.1M | |
| Income Taxes | -71.1M | -276.7M | -197.1M | -33.8M | ||
| Minority Interest | -25.0M | -24.8M | -30.3M | -22.9M | ||
| Net Income | 431.7M | 1.0B | 599.3M | 129.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.5B | 2.5B | 2.5B | 2.6B | |
| Shares To Calculate EPS Diluted | 2.5B | 2.5B | 2.5B | 2.6B | ||
| Earnings Per Share | EPS | $0.17 | $0.40 | $0.24 | $0.05 | |
| EPS Diluted | $0.17 | $0.40 | $0.24 | $0.05 | ||